Padsevonil
Showing 1 - 11 of 11
Healthy Study Participants, Impaired Hepatic Function Trial in Orlando (Padsevonil)
Terminated
- Healthy Study Participants
- Impaired Hepatic Function
- Padsevonil
-
Orlando, FloridaUp0056 004
Jul 8, 2021
Pharmacokinetics Trial in London (Padsevonil (UCB0942), Erythromycin)
Completed
- Pharmacokinetics
- Padsevonil (UCB0942)
- Erythromycin
-
London, United KingdomUp0057 001
Jun 18, 2021
Healthy Female Participants Trial in London (Padsevonil, Microgynon 30®)
Terminated
- Healthy Female Participants
- Padsevonil
- Microgynon 30®
-
London, United KingdomUp0035 001
Jun 22, 2021
Elderly Study Participants, Adult Study Participants Trial in San Antonio (Padsevonil)
Completed
- Elderly Study Participants
- Adult Study Participants
- Padsevonil
-
San Antonio, TexasUp0053 001
Jun 9, 2021
Healthy Participants Trial in Leiden (Padsevonil, Placebo (PSL))
Terminated
- Healthy Participants
- Padsevonil
- Placebo (PSL)
-
Leiden, NetherlandsUp0071 001
May 21, 2021
Healthy Participants, Epilepsy Trial (Padsevonil type 1 Tablet 200 mg, Padsevonil type 2 Tablet, Padsevonil type 3 Tablet)
Withdrawn
- Healthy Participants
- Epilepsy
- Padsevonil type 1 Tablet 200 mg
- +4 more
- (no location specified)
Jun 18, 2020
Drug-Resistant Epilepsy, Focal-Onset Seizures Trial in Worldwide (Padsevonil)
Terminated
- Drug-Resistant Epilepsy
- Focal-Onset Seizures
- Padsevonil
-
Chandler, Arizona
- +155 more
Nov 30, 2021
Drug-Resistant Epilepsy, Focal-Onset Seizures Trial in Worldwide (Padsevonil, Placebo)
Terminated
- Drug-Resistant Epilepsy
- Focal-Onset Seizures
- Padsevonil
- Placebo
-
Chandler, Arizona
- +140 more
Nov 29, 2021
Drug-resistant Epilepsy, Focal-Onset Seizures Trial in Worldwide (Padsevonil, Placebo)
Completed
- Drug-resistant Epilepsy
- Focal-Onset Seizures
- Padsevonil
- Placebo
-
Chandler, Arizona
- +147 more
Mar 16, 2021